Molecular and Cellular Biochemistry

, Volume 303, Issue 1–2, pp 115–120

A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family

  • Limei Liu
  • Hiroto Furuta
  • Asako Minami
  • Taishan Zheng
  • Weiping Jia
  • Kishio Nanjo
  • Kunsan Xiang



During examining the prevalence of mutations in NeuroD1/BETA2 gene in Chinese early-onset type 2 diabetic probands, a novel missense mutation, Ser159Pro in a potential MODY family was identified. To investigate the role of the mutation in early-onset diabetes, we studied its transcriptional activity on human insulin gene and clinical characteristics of the family with the mutation.


Bi-directional sequencing of NeuroD1/BETA2 was performed in 85 early-onset type 2 diabetic probands without mutations in HNF4α, glucokinase, HNF1α, IPF-1 and HNF1β genes, 95 late-onset type 2 diabetics with strong diabetic history and 87 non-diabetic control subjects. The function of the Ser159Pro to the transcription of a human insulin promotor-linked luciferase reporter gene in rat INS-1 cells was tested using Dual-Luciferase® Reporter Assay System. Clinical phenotypes of the family with the Ser159Pro mutation were examined and analyzed.


A novel mutation, Ser159Pro were found in a 27-years-old proband with both parents had diabetes. The mutation was transmitted in the heterozygous state and co-segregated with diabetes in four out of five carriers from the paternal side. Expect for the proband, all of other members with this mutation in the family, however, were diagnosed with diabetes after 50-years-old. The functional study showed that the mutant protein exhibited a 25% reduction in transcriptional activity of insulin gene when compared with the wild type.


These results suggest that the novel Ser159Pro mutation in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family.


NeuroD1/BETA2 gene Ser159Pro Early-onset type 2 diabetes mellitus MODY 



Neuro D1


Type 2 diabetes mellitus


Flag tagged full-length mouse neuroD1-Wild type cDNA


Flag tagged full-length mouse NeuroD1 mutant-type (Ser159Pro) cDNA


  1. 1.
    Fajans SS, Bell GI, Polonskyn KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971–980PubMedCrossRefGoogle Scholar
  2. 2.
    Ng MC, Lee SC, Ko GT et al (2001) Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity. Diabet Care 24:663–671CrossRefGoogle Scholar
  3. 3.
    Ng MC, Cockburn BN, Lindner TH et al (1999) Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclear factor-1alpha genes in patients with early-onset type 2 diabetes mellitus/MODY. Diabet Med 16(11):956–963PubMedCrossRefGoogle Scholar
  4. 4.
    Naya FJ, Stellrecht CM, Tsai MJ (1995) Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 9:1009–1019PubMedCrossRefGoogle Scholar
  5. 5.
    Tamimi R, Steingrimsson E, Copeland NG et al (1996) The NEUROD gene maps to human chromosome 2q32 and mouse chromosome 2. Genomics 34:418–421PubMedCrossRefGoogle Scholar
  6. 6.
    Naya FJ, Huang HP, Qiu Y et al (1997) Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD -deficient mice. Genes Dev 11(18):2323–2334PubMedGoogle Scholar
  7. 7.
    Huang HP, Chu K, Nemoz-Gaillard E et al (2002) Neogenesis of beta cells in adult BETA2/NeuroD-deficient mice. Mol Endocrinol 16(3):541–551PubMedCrossRefGoogle Scholar
  8. 8.
    Fajans SS, Bell GI, Polonsky KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971–980PubMedCrossRefGoogle Scholar
  9. 9.
    Malecki MT, Jhala US, Antonellis A et al (1999) Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23:323–328PubMedCrossRefGoogle Scholar
  10. 10.
    Kristinsson SY, Thorolfsdottir ET, Talseth B et al (2001) MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. Diabetologia 44(11):2098–2103PubMedCrossRefGoogle Scholar
  11. 11.
    The Expert Committee on the Diagnosis, Classification of Diabetes Mellitus (2003) Report of the Expert Committee On The Diagnosis And Classification Of Diabetes Mellitus (position statement). Diabet Care 26(Suppl 1):S5–S24Google Scholar
  12. 12.
    Frayling TM, Evans JC, Bulman MP et al (2001) Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50(Suppl 1):S94–S100PubMedCrossRefGoogle Scholar
  13. 13.
    Fukui M, Nakano K, Obayashi H et al (1997) High prevalence of mitochondrial diabetes mellitus in Japanese patients with major risk factors. Metabolism 46(7):793–795PubMedCrossRefGoogle Scholar
  14. 14.
    Sambrook J, Fritsch E, Maniatis T (1989) A laboratory manual. Molecular cloning, 2nd edn. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, P.E3–E4Google Scholar
  15. 15.
    Furuta H, Horikawa Y, Iwasaki N et al (1998) Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes 47(8):1356–1358PubMedCrossRefGoogle Scholar
  16. 16.
    Osawa H, Onuma H, Murakami A et al (2001) Systematic search for single nucleotide polymorphisms in the insulin gene: evidence for a high frequency of -23T→A in Japanese subjects. Biochem Biophys Res Commun 286(3):451–455PubMedCrossRefGoogle Scholar
  17. 17.
    Yamagata K, Furuta H, Oda N et al (1996) Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384:458–460PubMedCrossRefGoogle Scholar
  18. 18.
    Froguel P, Zouali H, Vionnet N (1993) Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328(10):697–702PubMedCrossRefGoogle Scholar
  19. 19.
    Yamagata K, Oda N, Kaisaki PJ et al (1996) Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384:455–458PubMedCrossRefGoogle Scholar
  20. 20.
    Chevre JC, Hani EH, Stoffers DA et al (1998) Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians. Diabetes 47(5):843–844PubMedCrossRefGoogle Scholar
  21. 21.
    Beards F, Frayling T, Bulman M et al (1998) Mutations in hepatocyte nuclear factor 1beta are not a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 47(7):1152–1154PubMedCrossRefGoogle Scholar
  22. 22.
    Liu L, Jia W, Zheng T et al (2006) Ala45Thr variation in neuroD1 gene is associated with early-onset type2 diabeteswithor without diabetic pedigree in Chinese. Mol Cell Biochem 290(1–2):199–204PubMedCrossRefGoogle Scholar
  23. 23.
    Sharma A, Moore M, Marcora E et al (1999) The NeuroD1/BETA2 sequence essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding. Mol Cell Biol 19:704–713PubMedGoogle Scholar
  24. 24.
    Khoo S, Griffen SC, Xia Y et al (2003) Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic beta cells. J Biol Chem, 278(35):32969–32977CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Limei Liu
    • 1
  • Hiroto Furuta
    • 2
  • Asako Minami
    • 2
  • Taishan Zheng
    • 1
  • Weiping Jia
    • 1
  • Kishio Nanjo
    • 2
  • Kunsan Xiang
    • 1
  1. 1.Department of Endocrinology & MetabolismShanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai Diabetes InstituteShanghaiChina
  2. 2.First Department of Internal MedicineWakayama Medical UniversityWakayamaJapan

Personalised recommendations